An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 2013
published in
- Chest Journal
has subject area
- Aged
- Antifungal Agents
- Cryptococcosis
- Cryptococcus neoformans
- Enzyme Inhibitors
- Fluconazole
- Humans
- Immunity, Cellular
- Janus Kinase 1
- Janus Kinase 2
- Lung
- Male
- Nitriles
- Opportunistic Infections
- Pneumonia, Bacterial
- Primary Myelofibrosis
- Pyrazoles
- Pyrimidines
- Tomography, X-Ray Computed
- Treatment Outcome